{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:03:51Z","timestamp":1785528231608,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01271-w","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:15:53Z","timestamp":1785309353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From cystogenesis to carcinogenesis in ADPKD: risk modeling and a multistep precision surveillance"],"prefix":"10.1007","volume":"49","author":[{"given":"Angeliki","family":"Margoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas A.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4527","authenticated-orcid":false,"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"1271_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-0043-57268","volume":"45","author":"P Vias","year":"2024","unstructured":"P. Vias et al., Renal cell carcinoma in the background of autosomal dominant polycystic kidney disease: report of two cases and review of literature. Indian J. Med. Paediatr. Oncol. 45, 188\u2013193 (2024). https:\/\/doi.org\/10.1055\/s-0043-57268","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"1271_CR2","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.ekir.2024.07.012","volume":"9","author":"A Ghanem","year":"2024","unstructured":"A. Ghanem et al., Biomarkers of kidney disease progression in ADPKD. Kidney Int. Rep. 9, 2860\u20132882 (2024). https:\/\/doi.org\/10.1016\/j.ekir.2024.07.012","journal-title":"Kidney Int. Rep."},{"key":"1271_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000536245","volume":"148","author":"AM Drake","year":"2024","unstructured":"A.M. Drake et al., Prevalence of renal neoplasia in autosomal dominant polycystic kidney disease: systematic review and meta-analysis. Nephron. 148, 457\u2013467 (2024). https:\/\/doi.org\/10.1159\/000536245","journal-title":"Nephron"},{"key":"1271_CR4","doi-asserted-by":"publisher","first-page":"2492374","DOI":"10.1080\/0886022X.2025.2492374","volume":"47","author":"AH Borghol","year":"2025","unstructured":"A.H. Borghol, M.T. Bou Antoun, C. Hanna, M. Salih, F.F. Rahbari-Oskoui, F.T. Chebib, Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances. Ren. Fail. 47, 2492374 (2025). https:\/\/doi.org\/10.1080\/0886022X.2025.2492374","journal-title":"Ren. Fail."},{"key":"1271_CR5","doi-asserted-by":"publisher","unstructured":"S. Subhash, A. Safadi, R. Bajpai, R. Raina, 2025 KDIGO executive summary: diagnosis and management of pediatric autosomal dominant polycystic kidney disease. Kidney Blood Press. Res. 51, 101\u2013106 (2026). https:\/\/doi.org\/10.1159\/000550103","DOI":"10.1159\/000550103"},{"key":"1271_CR6","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","volume":"29","author":"MB Lanktree","year":"2018","unstructured":"M.B. Lanktree et al., Prevalence estimates of polycystic kidney and liver disease by population sequencing. J. Am. Soc. Nephrol. 29, 2593\u20132600 (2018). https:\/\/doi.org\/10.1681\/ASN.2018050493","journal-title":"J. Am. Soc. Nephrol."},{"key":"1271_CR7","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"P.C. Harris, V.E. Torres, Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J. Clin. Invest. 124, 2315\u20132324 (2014). https:\/\/doi.org\/10.1172\/JCI72272","journal-title":"J. Clin. Invest."},{"key":"1271_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ndt\/gft521","volume":"29","author":"I Rowe","year":"2014","unstructured":"I. Rowe, A. Boletta, Defective metabolism in polycystic kidney disease: potential for therapy and open questions. Nephrol. Dial Transpl. 29, 1480\u20131486 (2014). https:\/\/doi.org\/10.1093\/ndt\/gft521","journal-title":"Nephrol. Dial Transpl."},{"key":"1271_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"C. Bergmann, L.M. Guay-Woodford, P.C. Harris, S. Horie, D.J.M. Peters, V.E. Torres, Polycystic kidney disease. Nat. Rev. Dis. Primers. 4, 50 (2018). https:\/\/doi.org\/10.1038\/s41572-018-0047-y","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1271_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0140-6736(26)00046-2","volume":"407","author":"ACM Ong","year":"2026","unstructured":"A.C.M. Ong, S. Carriazo, B.M. Ma, R. Torra, Y. Pei, Autosomal dominant polycystic kidney disease. Lancet. 407, 1289\u20131302 (2026). https:\/\/doi.org\/10.1016\/S0140-6736(26)00046-2","journal-title":"Lancet"},{"key":"1271_CR11","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"X. Song et al., Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum. Mol. Genet. 18, 2328\u20132343 (2009). https:\/\/doi.org\/10.1093\/hmg\/ddp165","journal-title":"Hum. Mol. Genet."},{"key":"1271_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2215\/CJN.0000000680","volume":"20","author":"T Bais","year":"2025","unstructured":"T. Bais et al., Predicting kidney outcomes in autosomal dominant polycystic kidney disease: a comprehensive biomarker analysis. Clin. J. Am. Soc. Nephrol. 20, 608\u2013618 (2025). https:\/\/doi.org\/10.2215\/CJN.0000000680","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1271_CR13","doi-asserted-by":"publisher","unstructured":"E. Cornec-Le Gall, A.C.M. Ong, Genetic testing in autosomal dominant polycystic kidney disease: why it matters in 2025. Clin. Kidney J. 18(Suppl. 2), ii17\u2013ii25 (2025). https:\/\/doi.org\/10.1093\/ckj\/sfaf331","DOI":"10.1093\/ckj\/sfaf331"},{"key":"1271_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le","year":"2018","unstructured":"E. Cornec-Le, V.E. Gall, P.C. Torres, Harris, Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J. Am. Soc. Nephrol. 29, 13\u201323 (2018). https:\/\/doi.org\/10.1681\/ASN.2017050483","journal-title":"J. Am. Soc. Nephrol."},{"key":"1271_CR15","doi-asserted-by":"publisher","unstructured":"B.N. Schmeusser et al., Creatinine to cystatin-C ratio in renal cell carcinoma: a clinically pragmatic prognostic factor and sarcopenia biomarker. Oncologist 28, e1219\u2013e1229 (2023). https:\/\/doi.org\/10.1093\/oncolo\/oyad218","DOI":"10.1093\/oncolo\/oyad218"},{"key":"1271_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","volume":"107","author":"VE Torres","year":"2025","unstructured":"V.E. Torres, C. Ahn, T.R.M. Barten, G. Brosnahan, M.A. Cadnapaphornchai, A.B. Chapman, KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int. 107, 234\u2013254 (2025). https:\/\/doi.org\/10.1016\/j.kint.2024.07.010","journal-title":"Kidney Int."},{"key":"1271_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"J.C.M. Wan et al., Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer. 17, 223\u2013238 (2017). https:\/\/doi.org\/10.1038\/nrc.2017.7","journal-title":"Nat. Rev. Cancer"},{"key":"1271_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/biomedicines13020523","volume":"13","author":"J Gu","year":"2025","unstructured":"J. Gu, F. Liu, L. Li, Mao. Advances and Challenges in Modeling Autosomal Dominant Polycystic Kidney Disease: A Focus on Kidney Organoids. Biomedicines. 13, 523 (2025). https:\/\/doi.org\/10.3390\/biomedicines13020523","journal-title":"Biomedicines"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01271-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01271-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01271-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:09Z","timestamp":1785521949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01271-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01271-w","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"100"}}